Bone Biologics announces annual shareholder meeting

• Bone Biologics will hold its annual shareholder meeting in Burlington, Massachusetts on Sept. 28, 2026.
• Shareholders will vote on electing four directors, an advisory say-on-pay resolution, and ratifying Weinberg & Company as auditor for 2026.
• Ballot also covers share issuance tied to warrants from a private placement, a proposed reverse stock split of 1-for-2 to 1-for-10.
• Separate proposal seeks authority to adjourn the meeting if needed to secure enough votes or establish a quorum.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Bone Biologics Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-26-039034), on August 18, 2026, and is solely responsible for the information contained therein.